Cannabis Lab Testing for Patients


How Lab Tests Help You

Prop 203

Medical Marijuana in Arizona

In 2010 Arizona approved Proposition 203, making it the 15th state to allow medical marijuana. Since the programs launch, there are now around 180,000 qualifying patients and is the third largest mmj program in the nation. Patients typically must be 18 years old, however there are special case scenarios in which children are given non-psychoactive doses of Cannabis.

Patients who qualify are legally allowed to possess 2.5 ounces of usable marijuana. 

The list for qualifying conditions set by the Arizona Department of Health Services is as follows:
  • Alzheimer's
  • Cachexia
  • Cancer
  • Chronic Pain
  • Crohn's Disease
  • Glaucoma
  • Hepatitis C
  • HIV/AIDS
  • Muscle Spasms
  • Nausea
  • Post-Traumatic Stress Disorder
  • Sclerosis
  • Seizures

Medical Benefits

THC vs. CBD

While scientists have identified over 100 different cannabinoids found in cannabis, THC & CBD are the two most prominent. Both compounds interact with the endocannabinoid system in your body to create the desired effects. The key difference between the two compounds is whether they produce a psychoactive experience for the user. 

Tetrahydrocannabinol (THC) 

Most commonly found in marijuana, psychoactive components. THC has anti-inflammatory properties and has been shown to be effective at providing pain relief, improving sleep, stimulating appetite, as well as managing nausea and vomiting.  

Cannabidiol (CBD)

Typically associated with hemp and infused products, non-psychoactive components. CBD also has anti-inflammatory properties and has been show to help relieve pain, reduce anxiety, relieve nausea, and induce cell death in certain cancers. CBD is commonly available in creams, oils and flower with low to no THC content.

Consumption Methods